Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.DN-d7ZPu.js ...

Get insights and exclusive content from the world of business and finance that you can trust, delivered to your inbox.

Four of our panelists discuss their favorite investments in the final installment of our 2025 stock-picking confab.

Region’s leading science-focused ecosystem set to explore healthspan and the UAE’s life science achievements at landmark 50th ...

Vadara Quartz Surfaces, a leading manufacturer of artisan handcrafted quartz surfaces, has begun an international expansion into the United ...

Vasella was hired by Sandoz back in 1988 and remained there until 1992 when he was promoted to CEO of its parent ... The company also acquired two generics companies: Durasacan from AstraZeneca ...

AstraZeneca PLC (LON:AZN), a leading global biopharmaceutical company with a market capitalization of $216.74 billion, has been making significant strides in the pharmaceutical industry, particularly ...

AstraZeneca PLC closed 16.10% below its 52-week high of £133.88, which the company reached on September 3rd.

Diversify Wealth Management LLC grew its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 3.6% during the ...

Understanding the enormous commercial potential of this market, the company continues to actively expand its portfolio of FDA-approved and experimental drugs. Overall, sales of AstraZeneca's ...

AstraZeneca received Food and Drug Administration approval for enhertu, its breast cancer treatment developed in partnership with Japanese company Daiichi Sankyo.

AstraZeneca, a global pharmaceutical company focused on developing life changing medicines, today announced a C$820 million (US$570m) investment in Canada, creating more than 700 high-skilled jobs ...